Targeting the CD40L Pathway in Transplantation: New Tricks for an Old Dog – Mandy Ford, PhD As a result of participation in this educational activity, members of the healthcare team will: Discuss clinically relevant concepts of the role of T cells in mediating transplant rejection. Explain clinically relevant concepts of the role of the CD154/CD40/CD11b pathway in contributing to transplant rejection. Identify new immunosuppressive drugs that are designed to target the CD154 pathway and thereby limit transplant rejection.
- Provider:University of Wisconsin-Madison Interprofessional Continuing Education Partnership
- Activity Link: https://ce.icep.wisc.edu/node/47976
- Start Date: 2024-04-03 05:00:00
- End Date: 2024-04-03 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours
Social Work: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery, Internal Medicine
Subscribe
Login
0 Comments
Oldest